Dihydroartemisinin inhibits HepG2.2.15 proliferation by inducing cellular senescence and autophagy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Dihydroartemisinin (DHA) has been reported to possess anti-cancer activity against many cancers. However, the pharmacologic effect of DHA on HBV-positive hepatocellular carcinoma (HCC) remains unknown. Thus, the objective of the present study was to determine whether DHA could inhibit the proliferation of HepG2.2.15 cells and uncover the underlying mechanisms involved in the effect of DHA on HepG2.2.15 cells. We found that DHA effectively inhibited HepG2.2.15 HCC cell proliferation both in vivo and in vitro. DHA also reduced the migration and tumorigenicity capacity of HepG2.2.15 cells. Regarding the underlying mechanisms, results showed that DHA induced cellular senescence by up-regulating expression levels of proteins such as p-ATM, p-ATR, -H2AX, P53, and P21 involved in DNA damage response. DHA also induced autophagy (green LC3 puncta gathered together and LC3II/LC3I ratio increased through AKT-mTOR pathway suppression). Results also revealed that DHA-induced autophagy was not linked to senescence or cell death. TPP1 (telomere shelterin) overexpression could not rescue DHA-induced anticancer activity (cell proliferation). Moreover, DHA down-regulated TPP1 expression. Gene knockdown of TPP1 caused similar phenotypes and mechanisms as DHA induced phenotypes and mechanisms in HepG2.2.15 cells. These results demonstrate that DHA might inhibit HepG2.2.15 cells proliferation through inducing cellular senescence and autophagy.
Abstract
Dihydroartemisinin (DHA) has been reported to possess anti-cancer activity against many cancers. However, the pharmacologic effect of DHA on HBV-positive hepatocellular carcinoma (HCC) remains unknown. Thus, the objective of the present study was to determine whether DHA could inhibit the proliferation of HepG2.2.15 cells and uncover the underlying mechanisms involved in the effect of DHA on HepG2.2.15 cells. We found that DHA effectively inhibited HepG2.2.15 HCC cell proliferation both in vivo and in vitro. DHA also reduced the migration and tumorigenicity capacity of HepG2.2.15 cells. Regarding the underlying mechanisms, results showed that DHA induced cellular senescence by up-regulating expression levels of proteins such as p-ATM, p-ATR, -H2AX, P53, and P21 involved in DNA damage response. DHA also induced autophagy (green LC3 puncta gathered together and LC3II/LC3I ratio increased through AKT-mTOR pathway suppression). Results also revealed that DHA-induced autophagy was not linked to senescence or cell death. TPP1 (telomere shelterin) overexpression could not rescue DHA-induced anticancer activity (cell proliferation). Moreover, DHA down-regulated TPP1 expression. Gene knockdown of TPP1 caused similar phenotypes and mechanisms as DHA induced phenotypes and mechanisms in HepG2.2.15 cells. These results demonstrate that DHA might inhibit HepG2.2.15 cells proliferation through inducing cellular senescence and autophagy.
참고문헌 (26)
- Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36cancers in 185 countries", CA Cancer J Clin, 68, pp.394~424 (2018)
- Mokdad AA, "Liver cirrhosis mortality in 187 countries between 1980 and 2010 : a systematic analysis", BMC Med, 12, pp.145~ (2014)
- Eastman RT, "Artemisinin-based combination therapies : a vital tool in efforts to eliminate malaria", Nat Rev Microbiol, 7, pp.864~874 (2009)
- Tong Y, "Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt", beta-catenin signaling, 2016, pp.7, 31413~31428
- Ontikatze T, "Dihydroartemisinin is a hypoxia-active anti-cancer drug in colorectal carcinoma cells", Front Oncol, 4, pp.116~ (2014)
- Li Y, "Dihydroartemisinin suppresses pancreatic cancer cells via a microRNA-mRNA regulatory network", Oncotarget, 7, pp.62460~62473 (2016)
- Liao K, "Dihydroartemisinin inhibits cell proliferation via AKT", GSK3beta, Int J Clin Exp Pathol, pp.2014, 7[DOI]
- Zhang S, "Dihydroartemisinin induces apoptosis in human gastric cancer cell line BGC-823 through activation of JNK1", 2 and p38 MAPK signaling pathways, 2017, pp.37, 174~180
- Thongchot S, "Dihydroartemisinin induces apoptosis and autophagy-dependent cell death in cholangiocarcinoma through a DAPK1-BECLIN1pathway", Mol Carcinog, 57, pp.1735~1750 (2018)
- Shi X, "Dihydroartemisinin induces autophagy-dependent death in human tongue squamous cell carcinoma cells through DNA double-strand breakmediated oxidative stress", Oncotarget, 8, pp.45981~45993 (2017)
- Amaravadi R, "Recent insights into the function of autophagy in cancer", Genes Dev, 30, pp.1913~1930 (2016)
- Acosta JC, "Senescence : a new weapon for cancer therapy", Trends Cell Biol, 22, pp.211~219 (2012)
- Itahana K, "Mechanisms of cellular senescence in human and mouse cells", Biogerontology, 5, pp.1~10 (2004)
- Chang BD, "Role of p53 and p21waf1", cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs, 1999, pp.18, 4808~4818
- Zhang Z, "Interaction between autophagy and senescence is required for dihydroartemisinin to alleviate liver fibrosis", Cell Death Dis, 8, pp.e2886~ (2017)
- Wang SY, "Core signaling pathways of survival", death in autophagy-related cancer networks, 2011, pp.43, 1263~1266
- Gao X, "Dihydroartemisinin induces endoplasmic reticulum stressmediated apoptosis in HepG2 human hepatoma cells", Tumori, 97, pp.771~780 (2011)
- Im E, "Dihydroartemisinin induced caspase-dependent apoptosis through inhibiting the specificity protein 1 pathway in hepatocellular carcinoma SK-Hep-1 cells", Life Sci, 192, pp.286~292 (2018)
- Qin G, "Dihydroartemisinin induces apoptosis preferentially via a Bim-mediated intrinsic pathway in hepatocarcinoma cells", Apoptosis, 20, pp.1072~1086 (2015)
- Zhang CZ, "Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma in vitro and in vivo", Biochem Pharmacol, 83, pp.1278~1289 (2012)
- Sun P, "PRAK is essential for ras-induced senescence and tumor suppression", Cell, 128, pp.295~308 (2007)
- Guo X, "Dysfunctional telomeres activate an ATM-ATR-dependent DNA damage response to suppress tumorigenesis", EMBO J, 26, pp.4709~4719 (2007)
- Liu X, "Novel dihydroartemisinin derivative DHA-37 induces autophagic cell death through upregulation of HMGB1 in A549 cells", Cell Death Dis, 9, pp.1048~ (2018)
- Qu C, "Dihydroartemisinin exerts anti-tumor activity by inducing mitochondrion and endoplasmic reticulum apoptosis and autophagic cell death in human glioblastoma cells", Mol Carcinog, 11, pp.310~ (2017)
- Chen C, "Structural insights into POT1-TPP1 interaction and POT1 C-terminal mutations in human cancer", Nat Commun, 8, pp.14929~ (2017)
- Kocak H, "Hoyeraal-Hreidarsson syndrome caused by a germline mutation in the TEL patch of the telomere protein TPP1", Genes Dev, 28, pp.2090~2102 (2014)